Seattle Genetics is a unique and innovative company that is advertised as being a company that has created an alternative to cancer treatment that avoids any harmful toxins from entering the body that are common from other treatments of the disease. This biotechnology company was founded by Clay Siegall who used his ingenuity to create and commercialize a unique anti-body treatment that not only kills the cancerous cells, but also does so without harming the healthy cells in the body. As the leading company in the anti-body drug conjugate industry, this drug delivers cell-killing agents that are delivered directly to the cancerous cells. Without targeting the non-target cells, this anti-body drug eliminates the toxic side effects that are a result of other cancer treatments such as chemotherapy as well as radiation. Seattle Genetics is a prime example of advancement as well as a new way to look at cancer treatment that can eliminate cancer without the harmful side effects.
The anti-body drug is specifically designed to attach the monoclonal anti-bodies. Other cures that this new drug can help with include autoimmune diseases and many other diseases that are currently in progress of being tested. Currently, Seattle Genetics is in collaboration with Takeda Pharmaceutical Company to have the best scientists and technology at the disposal of Clay Siegall who has dedicated his entire research to this new therapeutic anti-body drug. As this treatment is already allowed in over 60 countries around the world, there are more partnerships to be formed within the years to come.
With over 20 years of research over this newly tested cure to cancer, there are still many tests to be conducted. However, thanks to the innovation of Clay Siegall and his team, research will continue to grow and be funded with the hope that the cure will develop even more over time and with hard work.